Clearly lots of disappointment being felt by lots over the absence of a material move upwards in the share price.

Perhaps a bit of perspective might help...

Last quarter was the worst quarter for stock markets in ages.

In September the iShares Nasdaq Biotech EFT (IBB US) was down 11.3%. And this was after a 10.6% decline in August.

RVX also declined by 10% in August but in September it rose by 11%.

OK, so RVX shares were pretty weak over the Summer, but still, I think the relative strength in September was excellent when compared to the implosion in the Biotech sector.

Don't become despondent when we are just entering the final straight. It's been over a decade, would be a shame to run out of steam just before the finish line. The last few yards are always the hardest; those who make them have mental strength. Hold strong everyone.